Process View
The process in which ions are transported across a membrane such that the membrane potential changes in the repolarizing direction, toward the resting potential. For example, the repolarization during an action potential is in the direction from the positive membrane potential towards the negative resting potential.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "membrane repolarization"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 1.000 | Human | |
| YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 1.000 | Human | |
| YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 1.000 | Human | |
| KCNIP2 | Kv channel interacting protein 2 | 0.993 | ||
| KCNB1 | potassium voltage-gated channel, Shab-related subfamily, member 1 | 0.986 | Human | |
| DLG4 | discs, large homolog 4 (Drosophila) | 0.975 | ||
| KCNE1 | potassium voltage-gated channel, Isk-related family, member 1 | 0.934 | ||
| KCNQ1 | potassium voltage-gated channel, KQT-like subfamily, member 1 | 0.911 | ||
| OBSCN | obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | 0.886 | ||
| SCN5A | sodium channel, voltage-gated, type V, alpha subunit | 0.877 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.770 | Human | |
| LIN7B | lin-7 homolog B (C. elegans) | 0.761 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.746 | ||
| KCND2 | potassium voltage-gated channel, Shal-related subfamily, member 2 | 0.714 | Human | |
| ACTN2 | actinin, alpha 2 | 0.679 | ||
| CABP1 | calcium binding protein 1 | 0.618 | ||
| CALM1 | calmodulin 1 (phosphorylase kinase, delta) | 0.618 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.588 | Human | |
| SNTG2 | syntrophin, gamma 2 | 0.532 | Human | |
| ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | 0.487 | ||
| KCNA1 | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | 0.391 | Human | |
| MAPK12 | mitogen-activated protein kinase 12 | 0.359 | ||
| DMD | dystrophin | 0.341 | ||
| TJP1 | tight junction protein 1 (zona occludens 1) | 0.296 | ||
| CD177 | CD177 molecule | 0.227 | ||
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.225 | ||
| GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A | 0.218 | ||
| DTNA | dystrobrevin, alpha | 0.206 | ||
| GRIN2B | glutamate receptor, ionotropic, N-methyl D-aspartate 2B | 0.186 | ||
| ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | 0.169 | ||
| SPTB | spectrin, beta, erythrocytic | 0.167 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.159 | Human | |
| YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide | 0.152 | Human | |
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.133 | ||
| GRIN2C | glutamate receptor, ionotropic, N-methyl D-aspartate 2C | 0.126 | ||
| ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | 0.123 | ||
| DLGAP1 | discs, large (Drosophila) homolog-associated protein 1 | 0.122 | ||
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.117 | ||
| RHAG | Rh-associated glycoprotein | 0.111 | ||
| CLCN3 | chloride channel 3 | 0.094 | ||
| RYR2 | ryanodine receptor 2 (cardiac) | 0.090 | ||
| KCNA4 | potassium voltage-gated channel, shaker-related subfamily, member 4 | 0.089 | Human | |
| KCNIP1 | Kv channel interacting protein 1 | 0.081 | Human | |
| RHOA | ras homolog gene family, member A | 0.073 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.073 | Human | |
| CCKBR | cholecystokinin B receptor | 0.072 | ||
| KCNH1 | potassium voltage-gated channel, subfamily H (eag-related), member 1 | 0.069 | Human | |
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.068 | ||
| WWP1 | WW domain containing E3 ubiquitin protein ligase 1 | 0.065 | Human | |
| ANKRD13A | ankyrin repeat domain 13A | 0.061 | ||
| FBXL15 | F-box and leucine-rich repeat protein 15 | 0.060 | ||
| RNF11 | ring finger protein 11 | 0.056 | ||
| SCNN1B | sodium channel, nonvoltage-gated 1, beta | 0.054 | ||
| NLGN1 | neuroligin 1 | 0.053 | ||
| SMAD5 | SMAD family member 5 | 0.050 | ||
| TTN | titin | 0.049 | ||
| DNAJB5 | DnaJ (Hsp40) homolog, subfamily B, member 5 | 0.049 | ||
| KCNB2 | potassium voltage-gated channel, Shab-related subfamily, member 2 | 0.049 | Human | |
| APBA1 | amyloid beta (A4) precursor protein-binding, family A, member 1 | 0.044 | ||
| KCNC1 | potassium voltage-gated channel, Shaw-related subfamily, member 1 | 0.044 | ||
| RALB | v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) | 0.042 | ||
| NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 0.040 | ||
| BAI1 | brain-specific angiogenesis inhibitor 1 | 0.039 | ||
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.038 | Human | |
| SMAD7 | SMAD family member 7 | 0.036 | ||
| MYOZ1 | myozenin 1 | 0.035 | ||
| DPP6 | dipeptidyl-peptidase 6 | 0.035 | ||
| MARK2 | MAP/microtubule affinity-regulating kinase 2 | 0.035 | ||
| DLGAP2 | discs, large (Drosophila) homolog-associated protein 2 | 0.035 | ||
| ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | 0.034 | ||
| CDC25B | cell division cycle 25 homolog B (S. pombe) | 0.033 | ||
| UTRN | utrophin | 0.031 | ||
| KCNJ10 | potassium inwardly-rectifying channel, subfamily J, member 10 | 0.031 | Human | |
| KCNG3 | potassium voltage-gated channel, subfamily G, member 3 | 0.031 | Human | |
| SRRM4 | serine/arginine repetitive matrix 4 | 0.029 | ||
| ARHGAP22 | Rho GTPase activating protein 22 | 0.029 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.029 | ||
| ACTL6B | actin-like 6B | 0.029 | ||
| KCNJ9 | potassium inwardly-rectifying channel, subfamily J, member 9 | 0.029 | Human | |
| FOXD3 | forkhead box D3 | 0.026 | ||
| GRIN2D | glutamate receptor, ionotropic, N-methyl D-aspartate 2D | 0.025 | ||
| GNAO1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O | 0.025 | ||
| DLG2 | discs, large homolog 2 (Drosophila) | 0.025 | ||
| KCNA2 | potassium voltage-gated channel, shaker-related subfamily, member 2 | 0.025 | Human | |
| ACHE | acetylcholinesterase | 0.023 | ||
| CDK5R2 | cyclin-dependent kinase 5, regulatory subunit 2 (p39) | 0.023 | ||
| EHD1 | EH-domain containing 1 | 0.023 | ||
| ADRA1D | adrenergic, alpha-1D-, receptor | 0.023 | ||
| CYP46A1 | cytochrome P450, family 46, subfamily A, polypeptide 1 | 0.022 | ||
| SMAD1 | SMAD family member 1 | 0.022 | ||
| GRIK1 | glutamate receptor, ionotropic, kainate 1 | 0.022 | ||
| SLITRK3 | SLIT and NTRK-like family, member 3 | 0.022 | ||
| KCNF1 | potassium voltage-gated channel, subfamily F, member 1 | 0.022 | Human | |
| CSRP3 | cysteine and glycine-rich protein 3 (cardiac LIM protein) | 0.022 | ||
| SEZ6L | seizure related 6 homolog (mouse)-like | 0.021 | ||
| P2RX6 | purinergic receptor P2X, ligand-gated ion channel, 6 | 0.021 | ||
| HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A | 0.021 | ||
| SCN3B | sodium channel, voltage-gated, type III, beta | 0.021 | ||
| SFN | stratifin | 0.021 | Human | |
| CADM3 | cell adhesion molecule 3 | 0.021 | ||
| NPY | neuropeptide Y | 0.021 | ||
| GRIN1 | glutamate receptor, ionotropic, N-methyl D-aspartate 1 | 0.020 | ||
| CAMK2B | calcium/calmodulin-dependent protein kinase II beta | 0.020 | ||
| HRH3 | histamine receptor H3 | 0.020 | ||
| ARRDC3 | arrestin domain containing 3 | 0.020 | ||
| GRM7 | glutamate receptor, metabotropic 7 | 0.020 | ||
| SPG20 | spastic paraplegia 20 (Troyer syndrome) | 0.019 | ||
| PTPRN | protein tyrosine phosphatase, receptor type, N | 0.019 | ||
| GRIA3 | glutamate receptor, ionotrophic, AMPA 3 | 0.019 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.019 | ||
| TUBB2B | tubulin, beta 2B | 0.019 | ||
| BSN | bassoon (presynaptic cytomatrix protein) | 0.019 | ||
| USP2 | ubiquitin specific peptidase 2 | 0.019 | ||
| SMAD4 | SMAD family member 4 | 0.018 | ||
| RIMS1 | regulating synaptic membrane exocytosis 1 | 0.018 | ||
| RALA | v-ral simian leukemia viral oncogene homolog A (ras related) | 0.018 | ||
| RIMBP2 | RIMS binding protein 2 | 0.018 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.018 | ||
| SYN2 | synapsin II | 0.018 | ||
| KCNA5 | potassium voltage-gated channel, shaker-related subfamily, member 5 | 0.018 | ||
| KCNQ2 | potassium voltage-gated channel, KQT-like subfamily, member 2 | 0.018 | Human | |
| ST8SIA5 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 | 0.018 | ||
| RGS6 | regulator of G-protein signaling 6 | 0.017 | ||
| PRKCG | protein kinase C, gamma | 0.017 | ||
| VSTM2A | V-set and transmembrane domain containing 2A | 0.017 | ||
| KCNJ16 | potassium inwardly-rectifying channel, subfamily J, member 16 | 0.017 | Human | |
| UNC13A | unc-13 homolog A (C. elegans) | 0.017 | ||
| ING1 | inhibitor of growth family, member 1 | 0.017 | ||
| ADAM11 | ADAM metallopeptidase domain 11 | 0.016 | ||
| GRIK5 | glutamate receptor, ionotropic, kainate 5 | 0.016 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.016 | ||
| GRIA1 | glutamate receptor, ionotropic, AMPA 1 | 0.016 | ||
| RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0.016 | ||
| NELL1 | NEL-like 1 (chicken) | 0.016 | ||
| CNTN2 | contactin 2 (axonal) | 0.015 | ||
| NECAB2 | N-terminal EF-hand calcium binding protein 2 | 0.015 | ||
| CACNB4 | calcium channel, voltage-dependent, beta 4 subunit | 0.015 | ||
| GAD2 | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) | 0.015 | ||
| KCNQ3 | potassium voltage-gated channel, KQT-like subfamily, member 3 | 0.015 | Human | |
| DTNB | dystrobrevin, beta | 0.015 | ||
| MAP1A | microtubule-associated protein 1A | 0.015 | ||
| NOS1 | nitric oxide synthase 1 (neuronal) | 0.015 | ||
| SCNN1G | sodium channel, nonvoltage-gated 1, gamma | 0.015 | ||
| KCNIP4 | Kv channel interacting protein 4 | 0.015 | Human | |
| CPLX2 | complexin 2 | 0.014 | ||
| SCN2B | sodium channel, voltage-gated, type II, beta | 0.014 | Human | |
| CXXC5 | CXXC finger protein 5 | 0.014 | ||
| SPTA1 | spectrin, alpha, erythrocytic 1 (elliptocytosis 2) | 0.014 | ||
| DDN | dendrin | 0.014 | ||
| HECW1 | HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 | 0.014 | ||
| CACNA1C | calcium channel, voltage-dependent, L type, alpha 1C subunit | 0.014 | Human | |
| ADCYAP1R1 | adenylate cyclase activating polypeptide 1 (pituitary) receptor type I | 0.014 | ||
| KCNAB1 | potassium voltage-gated channel, shaker-related subfamily, beta member 1 | 0.014 | ||
| ATP1B2 | ATPase, Na+/K+ transporting, beta 2 polypeptide | 0.014 | ||
| GRIK4 | glutamate receptor, ionotropic, kainate 4 | 0.014 | ||
| KCNA6 | potassium voltage-gated channel, shaker-related subfamily, member 6 | 0.014 | Human | |
| PRDM8 | PR domain containing 8 | 0.014 | ||
| KCND3 | potassium voltage-gated channel, Shal-related subfamily, member 3 | 0.013 | ||
| WSCD1 | WSC domain containing 1 | 0.013 | ||
| SLC1A6 | solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | 0.013 | ||
| GRM5 | glutamate receptor, metabotropic 5 | 0.013 | ||
| CDH8 | cadherin 8, type 2 | 0.013 | ||
| CACNA1E | calcium channel, voltage-dependent, R type, alpha 1E subunit | 0.013 | Human | |
| TRPM3 | transient receptor potential cation channel, subfamily M, member 3 | 0.013 | ||
| GRM3 | glutamate receptor, metabotropic 3 | 0.013 | ||
| ABCC9 | ATP-binding cassette, sub-family C (CFTR/MRP), member 9 | 0.013 | ||
| GRM1 | glutamate receptor, metabotropic 1 | 0.013 | ||
| OPRM1 | opioid receptor, mu 1 | 0.013 | ||
| BZRAP1 | benzodiazapine receptor (peripheral) associated protein 1 | 0.013 | ||
| NRXN1 | neurexin 1 | 0.012 | ||
| ADCYAP1 | adenylate cyclase activating polypeptide 1 (pituitary) | 0.012 | ||
| WNK1 | WNK lysine deficient protein kinase 1 | 0.012 | ||
| CCDC48 | coiled-coil domain containing 48 | 0.012 | ||
| TMEM59L | transmembrane protein 59-like | 0.012 | ||
| PGAM2 | phosphoglycerate mutase 2 (muscle) | 0.012 | ||
| MAPK4 | mitogen-activated protein kinase 4 | 0.012 | ||
| FXYD7 | FXYD domain containing ion transport regulator 7 | 0.012 | ||
| KIF1A | kinesin family member 1A | 0.012 | ||
| SLC17A7 | solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 | 0.012 | ||
| PDZK1 | PDZ domain containing 1 | 0.012 | ||
| CAMK2A | calcium/calmodulin-dependent protein kinase II alpha | 0.012 | ||
| KCNA3 | potassium voltage-gated channel, shaker-related subfamily, member 3 | 0.012 | Human | |
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.012 | ||
| BCAN | brevican | 0.012 | ||
| SLC4A3 | solute carrier family 4, anion exchanger, member 3 | 0.012 | ||
| FAM5B | family with sequence similarity 5, member B | 0.012 | ||
| ACTN3 | actinin, alpha 3 | 0.012 | ||
| NDRG2 | NDRG family member 2 | 0.012 | ||
| SCN4A | sodium channel, voltage-gated, type IV, alpha subunit | 0.012 | ||
| CACNA1B | calcium channel, voltage-dependent, N type, alpha 1B subunit | 0.011 | Human | |
| RNF168 | ring finger protein 168 | 0.011 | ||
| GRIK3 | glutamate receptor, ionotropic, kainate 3 | 0.011 | ||
| SNCB | synuclein, beta | 0.011 | ||
| GLRA1 | glycine receptor, alpha 1 | 0.011 | ||
| KCNJ3 | potassium inwardly-rectifying channel, subfamily J, member 3 | 0.011 | ||
| LDB3 | LIM domain binding 3 | 0.011 | ||
| NCAN | neurocan | 0.011 | ||
| MEGF8 | multiple EGF-like-domains 8 | 0.011 | ||
| SGCA | sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) | 0.011 | ||
| SOX7 | SRY (sex determining region Y)-box 7 | 0.011 | ||
| GHSR | growth hormone secretagogue receptor | 0.011 | ||
| TMEM130 | transmembrane protein 130 | 0.011 | ||
| CACNG2 | calcium channel, voltage-dependent, gamma subunit 2 | 0.011 | ||
| LPHN1 | latrophilin 1 | 0.011 | ||
| KCNJ6 | potassium inwardly-rectifying channel, subfamily J, member 6 | 0.011 | Human | |
| JPH3 | junctophilin 3 | 0.011 | ||
| ESRRB | estrogen-related receptor beta | 0.011 | ||
| RIT2 | Ras-like without CAAX 2 | 0.011 | ||
| CRIPT | cysteine-rich PDZ-binding protein | 0.011 | ||
| OPRK1 | opioid receptor, kappa 1 | 0.011 | ||
| FXYD1 | FXYD domain containing ion transport regulator 1 | 0.011 | ||
| CACNG3 | calcium channel, voltage-dependent, gamma subunit 3 | 0.011 | ||
| KCNH6 | potassium voltage-gated channel, subfamily H (eag-related), member 6 | 0.011 | Human | |
| LRTM2 | leucine-rich repeats and transmembrane domains 2 | 0.010 | ||
| CNTN6 | contactin 6 | 0.010 | ||
| FBXO40 | F-box protein 40 | 0.010 | ||
| GFAP | glial fibrillary acidic protein | 0.010 | ||
| ARHGEF4 | Rho guanine nucleotide exchange factor (GEF) 4 | 0.010 | ||
| KCNN3 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 | 0.010 | ||
| PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.010 | ||
| HPCA | hippocalcin | 0.010 | ||
| BAD | BCL2-associated agonist of cell death | 0.010 | ||
| ADCY8 | adenylate cyclase 8 (brain) | 0.010 | ||
| GABRD | gamma-aminobutyric acid (GABA) A receptor, delta | 0.010 | ||
| SCN2A | sodium channel, voltage-gated, type II, alpha subunit | 0.010 | ||
| CA10 | carbonic anhydrase X | 0.010 | ||
| TTYH1 | tweety homolog 1 (Drosophila) | 0.010 | ||
| TACR1 | tachykinin receptor 1 | 0.010 | ||
| HPCAL4 | hippocalcin like 4 | 0.010 |